37 related articles for article (PubMed ID: 16495766)
1. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.
Chung M; Vashi V; Puente J; Sweeney M; Meredith P
Br J Clin Pharmacol; 1999 Nov; 48(5):678-87. PubMed ID: 10594469
[TBL] [Abstract][Full Text] [Related]
2. Doxazosin added to single-drug therapy in hypertensive patients with benign prostatic hypertrophy.
Martell N; Luque M;
J Clin Hypertens (Greenwich); 2001; 3(4):218-23. PubMed ID: 11498652
[TBL] [Abstract][Full Text] [Related]
3. (-)Doxazosin is a necessary component for the hypotensive effect of (±)doxazosin during long-term administration in conscious rats.
Zhao J; Kong DZ; Li Q; Zhen YQ; Wang M; Zhao Y; Wang DK; Ren LM
Acta Pharmacol Sin; 2014 Jan; 35(1):48-57. PubMed ID: 24335843
[TBL] [Abstract][Full Text] [Related]
4. Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study.
Zhang K; Yu W; Jin J; Ye H; Wang X; Zhang N; Yang Y; Zhong C; Wan B
Urology; 2011 Sep; 78(3):636-40. PubMed ID: 21696807
[TBL] [Abstract][Full Text] [Related]
5. Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?
Chapman N; Chen CY; Fujita T; Hobbs FD; Kim SJ; Staessen JA; Tanomsup S; Wang JG; Williams B
J Hypertens; 2010 Sep; 28(9):1796-803. PubMed ID: 20543713
[TBL] [Abstract][Full Text] [Related]
6. Add-on therapy with doxazosin in patients with hypertension influences arterial stiffness and albuterol-mediated arterial vasodilation.
Wykretowicz A; Guzik P; Krauze T; Adamska K; Milewska A; Wysocki H
Br J Clin Pharmacol; 2007 Dec; 64(6):792-5. PubMed ID: 17635498
[TBL] [Abstract][Full Text] [Related]
7. Clinical ease of using doxazosin in BPH patients with and without hypertension.
Steers WD; Kirby RS
Prostate Cancer Prostatic Dis; 2005; 8(2):152-7. PubMed ID: 15711605
[TBL] [Abstract][Full Text] [Related]
8. [Cardura XL--a unique drug formulation--doxazosine administered in a slow-release form (doxazosine GITS)].
Grzeszczak W
Przegl Lek; 2000; 57(11):643-54. PubMed ID: 11293213
[TBL] [Abstract][Full Text] [Related]
9. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.
de Alvaro F; Hernández-Presa MA;
J Cardiovasc Pharmacol; 2006 Feb; 47(2):271-6. PubMed ID: 16495766
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
Chung BH; Hong SJ
BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335
[TBL] [Abstract][Full Text] [Related]
12. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B
Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390
[TBL] [Abstract][Full Text] [Related]
13. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR;
Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700
[TBL] [Abstract][Full Text] [Related]
14. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
